HPLC-MS/MS联用技术定量测定人血浆中奥洛他定浓度

Quantitative Determination of Olopatadine in Human Plasma by High-Performance Liquid ChromatographyTandem Mass Spectrometry

  • 摘要: 建立HPLC-MS/MS方法定量测定人血浆中奥洛他定浓度。血浆样品在酸性条件下,经Tomtec全自动固相萃取仪处理后,以v(甲醇):v(0.05%甲酸)=50∶50溶液为流动相,经Alltima C18色谱柱初步分离,利用串联质谱在正离子电离模式下,以多反应离子监测(MRM)方式定量测定奥洛他定及其内标。结果表明:奥洛他定的最低定量浓度为0.1 ng/mL,线性范围为0.1~100 ng/mL,精密度和准确度均在±15%以内。此方法专属、灵敏、准确,可以用于测定人血浆中奥洛他定浓度。

     

    Abstract: A sensitive and specific HPLC-MS/MS method was developed for the quantitative determination of olopatadine in human plasma. Plasma samples were prepared by Tomtec automatic SPE device and separated on an Alltima C18 column with methanol∶0.05% formic acid=50∶50 (v/v) as the mobile phase. Detection was performed on a triple-quadrupole tandem mass spectrometer using positive electrospray ionization (ESI), and multiple reaction monitoring (MRM) was applied. The results showed the lowest limit of quantitation of olopatadine was 0.1 ng/mL, and the linear range was 0.1~100 ng/mL. Accuracies and precisions of all were within ±15%. This method proved to be specific, sensitive and accurately, which can be applied to determine olopatadine in human plasma.

     

/

返回文章
返回